Wheelchair Provision Time for Hospital Inpatients

NCT06566040 | Suspended

• 1 other identifier: REB1030610
• Study Type: observational
• Target: 119
• Locations: 1 country
• Sites: 1

Brief Summary

In a Pilot Study, the median Wheelchair Lead Time (from when a wheelchair was ordered by an Occupational Therapist for an inpatient in the Central Zone of Nova Scotia Health to when the wheelchair arrived at the destination facility) of 119 wheelchairs was 2.98 days, with median Wheelchair Assembly Time and Wheelchair Delivery Time components of 0.98 and 1.00 days respectively. (For the over 3,000 inpatients/year for whom an order is placed, Wheelchair Delivery Time is not routinely recorded.) Reductions in Wheelchair Lead Time have the potential to speed patient mobilization (with benefits to the patient) and reduce both the patient's hospital Length of Stay and the patient-related Cost of Hospitalization. However, these potential benefits remain speculative. The objective of this project is to test the hypotheses that there are significant positive associations between Wheelchair Lead Time and both Length of Stay and the Cost of Hospitalization.

Conditions

Wheelchairs

Outcome Measures

Primary Outcomes (1)

• Wheelchair Lead Time

  Time from order placement to delivery to hospital site

  Through initial study completion in 1 year

Secondary Outcomes (2)

• Length of stay

  Through initial study completion in 1 year

• Case cost

  Through initial study completion in 1 year

Interventions

Wheelchair DEVICE

Wheelchairs provided to hospital inpatients

Eligibility Criteria

• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Patients hospitalized in the Central Zone of Nova Scotia Health for whom a wheelchair was ordered using the WheelEase software.

You may qualify if:

• to have been an inpatient in a Central Zone hospital site during the 11-weekday study period in late January 2023
• , to have had a WheelEase order placed during the 11-weekday study period in late January 2023
• to have had a Wheelchair Delivery Time recorded
• to have been subsequently discharged from a Central Zone hospital site.

You may not qualify if:

• if the WheelEase order was cancelled before delivery.

Sponsors & Collaborators

• Nova Scotia Health Authority: lead

Study Sites (1)

Nova Scotia Health Authority

Halifax, Nova Scotia, B3H4K4, Canada

Location

MeSH Terms

Interventions

Wheelchairs

Intervention Hierarchy (Ancestors)

Self-Help Devices; Equipment and Supplies

Study Officials

• Ronald L Kirby, MD

  Dalhousie University

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: RETROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: June 21, 2024
• First Posted: August 22, 2024
• Study Start: October 1, 2024
• Primary Completion: December 31, 2025
• Study Completion (Estimated): June 1, 2026
• Last Updated: February 18, 2025

Record last verified: 2024-08

Data Sharing

• IPD Sharing: Will not share

Locations

CA (1)